Papillomavirus Infections: Clinical Trials

760 trials for Papillomavirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

420 completed, 112 unknown, 79 recruiting, 57 active not recruiting. 210 Not applicable, 149 Phase 3, 140 Phase 2, 54 Phase 1, 47 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable210Completed 104, Unknown 38, Recruiting 33, Active not recruiting 15, Not yet recruiting 14, Terminated 3, Enrolling by invitation 2, Withdrawn 1
Phase 3149Completed 96, Active not recruiting 18, Unknown 18, Recruiting 5, Not yet recruiting 4, Terminated 4, Withdrawn 4
Phase 2140Completed 77, Recruiting 17, Not yet recruiting 12, Unknown 11, Terminated 10, Active not recruiting 6, Withdrawn 5, Enrolling by invitation 1, Suspended 1
Phase 154Completed 34, Recruiting 6, Not yet recruiting 4, Terminated 4, Unknown 3, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Phase 447Completed 21, Unknown 9, Recruiting 8, Active not recruiting 6, Terminated 2, Enrolling by invitation 1
Early Phase 16Completed 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Papillomavirus Infections: new trials by email Literature Review of Papillomavirus Infections trials Research Report on Papillomavirus Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart
Phase 2SuspendedG&E Herbal Biotechnology Co., LTD1022030-09-012023-09-14
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines
Not applicableNot yet recruitingUniversity of Florida12962027-09-152026-09-14
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection
WithdrawnAIDS Malignancy Consortium2027-04-302025-06-06
PROTECT-HER KIT to Improve HPV Self-Sampling Uptake Among Women in Selangor
PROTECT-HER KIT (Protection Motivation Theory-Based HPV Screening Education Kit), Standard Ministry of Health (MOH) Educational Materials - Cervical Cancer Screening, Human Papillomavirus Infection
Not applicableNot yet recruitingUniversiti Teknologi Mara1062027-03-012026-11-17
Efficacy and Safety of Oral Ivermectin for Genital Warts
Ivermectin - Genital Warts
Not applicableNot yet recruitingUniversity of Health Sciences Lahore902027-02-202026-11-03
Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs
ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingAbramson Cancer Center at Penn Medicine352027-01-312026-10-27
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Zopapogene imadenovec-drba - Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis
Phase 3Not yet recruitingPrecigen, Inc152026-12-312026-10-28
High-risk HPV Testing With Pap Smear Triage for Cervical Cancer Screening in Women Aged 50 and Older in Ethiopia
Uterine Cervical Neoplasms, Papillomavirus Infections
Not yet recruitingUniversity Medical Center Groningen30002026-12-012026-11-10
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection
Phase 2Not yet recruitingUNC Lineberger Comprehensive Cancer Center1402026-12-012026-11-17
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
PRGN-2012, Bevacizumab - Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Phase 2Not yet recruitingNational Cancer Institute (NCI)502026-11-252026-11-20
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
10vHPV, Gardasil9 - Human Papillomavirus Infection
Phase 1 / Phase 2Not yet recruitingSerum Institute of India Pvt. Ltd.722026-11-012026-11-06
Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
Busulfan, Palifermin, Plerixafor - WHIM, Warts
Phase 1 / Phase 2Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)102026-10-212026-10-27
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Dose de-escalation to contralateral neck., Dose de-escalation to gross disease to contralateral neck, Dose de-escalation to gross disease - Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Phase 2RecruitingUniversity of Maryland, Baltimore1322026-10-192026-11-06
A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)
V503, Placebo - Papillomavirus Infections
Phase 3RecruitingMerck Sharp & Dohme LLC9302026-10-102026-10-22
Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts
Intralesional Acyclovir, Intralesional Zinc Sulphate - Warts, Plantar Warts
Phase 3Not yet recruitingAssiut University762026-10-012026-09-29
Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression
Anal Self-Sampling for High-Risk HPV Detection - Human Papillomavirus Infection, Anal HPV Infection
Not applicableNot yet recruitingUniversity Hospital, Montpellier1902026-10-012026-10-05
Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children
Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine, Tetanus-Diphtheria booster - Human Papillomavirus (HPV) Infection
Phase 3Not yet recruitingPT Bio Farma2662026-10-012026-09-17
Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)
VP-102 - Common Warts, Common Warts (Verruca Vulgaris)
Phase 2Not yet recruitingVerrica Pharmaceuticals Inc.302026-10-012026-10-20
AVL-102 for the Treatment of HPV 16/18/52/58-Related High-Grade Lesions
AVL-102 Injection - CIN 2/3, HPV Infections
Phase 1RecruitingBeijing Xunsheng Biomedical Research Co., Ltd.122026-09-232026-11-17

Showing 20 of 760. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (192)  ·  Warts (121)  ·  Condylomata Acuminata (113)  ·  Uterine Cervical Dysplasia (60)  ·  HIV Infections (42)  ·  Anus Neoplasms (31)  ·  Vulvar Neoplasms (25)  ·  Squamous Intraepithelial Lesions (24)  ·  Vaginal Neoplasms (24)  ·  Infections (22)  ·  Oropharyngeal Neoplasms (19)  ·  Squamous Cell Carcinoma of Head and Neck (18)  ·  Neoplasms (17)  ·  Precancerous Conditions (15)

Broader conditions

DNA Virus Infections (753)  ·  Tumor Virus Infections (753)  ·  Virus Diseases (747)  ·  Infections (738)  ·  Pathological Conditions, Signs and Symptoms (654)  ·  Communicable Diseases (652)  ·  Urogenital Diseases (652)  ·  Genital Diseases (651)  ·  Pathologic Processes (651)  ·  Disease Attributes (650)  ·  Sexually Transmitted Diseases, Viral (649)  ·  Sexually Transmitted Diseases (641)  ·  Neoplasms (278)  ·  Neoplasms by Site (241)  ·  Female Urogenital Diseases and Pregnancy Complications (235)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (45)  ·  human papillomavirus vaccine, L1 type 16, 18 (43)  ·  Papillomavirus Vaccines (26)  ·  Cryotherapy (15)  ·  Human Papillomavirus Recombinant Vaccine nonavalent (14)  ·  Vaccines (14)  ·  Vaccines, Synthetic (14)  ·  Blood Specimen Collection (10)  ·  Colposcopy (9)  ·  Data Collection (9)  ·  Human Papillomavirus DNA Tests (8)  ·  Cisplatin (7)  ·  Imiquimod (7)  ·  Radiotherapy, Intensity-Modulated (7)  ·  Specimen Handling (7)

Sponsors

GlaxoSmithKline (71)  ·  Merck Sharp & Dohme LLC (50)  ·  National Cancer Institute (NCI) (20)  ·  Assiut University (13)  ·  Shanghai Bovax Biotechnology Co., Ltd. (13)  ·  AIDS Malignancy Consortium (8)  ·  Graceway Pharmaceuticals, LLC (8)  ·  University of Washington (8)  ·  Duke University (7)  ·  Fujian Maternity and Child Health Hospital (7)  ·  Xiamen University (7)  ·  Aclaris Therapeutics, Inc. (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (6)  ·  Shanghai Zerun Biotechnology Co.,Ltd (6)  ·  University Hospital, Geneva (6)

Countries

United States (221)  ·  China (89)  ·  France (32)  ·  Canada (28)  ·  Italy (23)  ·  Germany (21)  ·  Spain (21)  ·  Turkey (Türkiye) (21)  ·  Belgium (19)  ·  Taiwan (18)  ·  Egypt (17)  ·  United Kingdom (16)  ·  Australia (15)  ·  Thailand (15)  ·  Brazil (12)

Top investigators

Joel Palefsky, MD (5)  ·  Jun Zhang, Master (5)  ·  Jun Zhang, master (4)  ·  Scott M Norberg, D.O. (4)  ·  Ting Huang (4)  ·  Vikrant V Sahasrabuddhe (4)  ·  Yongjiang Liu, Bachelor (4)  ·  Deanna Kepka, PhD, MPH (3)  ·  Lameck Chinula, MD (3)  ·  Lei Li, M.D. (3)  ·  Pengming Sun (3)  ·  Rachel L Winer, PhD, MPH (3)

Results publications

PMID 41276263, PMID 27422279, PMID 19935017, PMID 32184277, PMID 31824976, PMID 19236277, PMID 19236279, PMID 24731816, PMID 25424785, PMID 25424918, PMID 29074187, PMID 29211620, PMID 30982556, PMID 33857679, PMID 35149535, PMID 41166720, PMID 15897380, PMID 17628649, PMID 18515521, PMID 19586656, PMID 20949623, PMID 21471141, PMID 22265115, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23336207, PMID 23632723, PMID 25057165, PMID 25273231, PMID 25424783, PMID 27566633, PMID 29214505, PMID 29269325, PMID 29767739, PMID 29995724, PMID 31464859, PMID 32078808, PMID 32827835, PMID 33326342, PMID 33538338, PMID 34939897, PMID 10693114, PMID 10782451, PMID 11238198, PMID 11927495, PMID 12807939, PMID 13519856, PMID 14682443, PMID 15153912

NIH funding

U01CA121947 (7), 2004 (5), 2009 (3), 2016 (3), 2017 (3), 2018 (3), 2023 (3), R01CA279973 (3), 2005 (2), 2008 (2), U01IP001073 (2), U24CA275417 (2), U54CA242639 (2), UG1CA275403 (2), UM1CA121947 (2)